Literature DB >> 20372841

Characterization of primary ovarian cancer cells in different culture systems.

Te Liu1, Weiwei Cheng, Dongmei Lai, Yong Huang, Lihe Guo.   

Abstract

The concept of cancer stem cells (CSCs) provides a new paradigm for understanding cancer biology. Here we report how culture conditions affect the characteristics of primary ovarian cancer cells. Cancer cells disaggregated from ovarian serous adenocarcinoma and maintained in serum-free system culture formed sphere cells that exhibited several properties expected for CSCs. These include self-renewal, overexpression of stemness genes as detected by QPCR analysis, greater tumorigenicity and enhanced drug resistance. The serum-free culture system enriched the percentage of CD133+/CD117+ expressing cells in sphere cells as determined by flow cytometric analysis, immunostaining and Western blot analysis. A cDNA microarray showed that there were 2111 genes exhibiting more than a 2-fold difference in expression. Subsequent ontological analysis revealed that a large proportion of the classified genes were related to cell communication, cell-cell adhesion, cellular development and extracellular matrix. We suggest that the sphere cell subpopulation may be a more reliable model than differentiated cells grown in the presence of serum for understanding the biology of primary ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20372841     DOI: 10.3892/or_00000761

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  22 in total

1.  Cisplatin targets the stromal cell-derived factor-1-CXC chemokine receptor type 4 axis to suppress metastasis and invasion of ovarian cancer-initiating cells.

Authors:  Zhi-hua Yu; Te Liu; Yan-hui Zhao; Yong-yi Huang; Yong-tao Gao
Journal:  Tumour Biol       Date:  2014-01-10

Review 2.  Cancer stem cells and drug resistance: the potential of nanomedicine.

Authors:  Serguei Vinogradov; Xin Wei
Journal:  Nanomedicine (Lond)       Date:  2012-04       Impact factor: 5.307

3.  microRNA-182 inhibits the proliferation and migration of glioma cells through the induction of neuritin expression.

Authors:  Y A Feng; T E Liu; Yuncheng Wu
Journal:  Oncol Lett       Date:  2015-06-11       Impact factor: 2.967

Review 4.  Cancer stem cells and chemoresistance: The smartest survives the raid.

Authors:  Jihe Zhao
Journal:  Pharmacol Ther       Date:  2016-02-17       Impact factor: 12.310

Review 5.  Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.

Authors:  Xiaoxiang Chen; Jing Zhang; Zhihong Zhang; Hongxia Li; Wenjun Cheng; Jinsong Liu
Journal:  Hum Pathol       Date:  2013-07-11       Impact factor: 3.466

6.  Evaluation of stem cell properties in human ovarian carcinoma cells using multi and single cell-based spheres assays.

Authors:  Hui Wang; Anna Paczulla; Claudia Lengerke
Journal:  J Vis Exp       Date:  2015-01-03       Impact factor: 1.355

Review 7.  Ovarian cancer stem cells: are they real and why are they important?

Authors:  Monjri M Shah; Charles N Landen
Journal:  Gynecol Oncol       Date:  2013-12-07       Impact factor: 5.482

8.  EZH2-specific microRNA-98 inhibits human ovarian cancer stem cell proliferation via regulating the pRb-E2F pathway.

Authors:  Te Liu; Lengchen Hou; Yongyi Huang
Journal:  Tumour Biol       Date:  2014-04-27

9.  Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.

Authors:  X Luo; Z Dong; Y Chen; L Yang; D Lai
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

10.  KLF5 strengthens drug resistance of ovarian cancer stem-like cells by regulating survivin expression.

Authors:  Z Dong; L Yang; D Lai
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.